Higher Levels of Stress-Related Hair Steroid Hormones Are Associated with the Increased SCORE2 Risk Prediction Algorithm in Apparently Healthy Women.

cardiovascular disease risk chronic stress hair steroid hormones

Journal

Journal of cardiovascular development and disease
ISSN: 2308-3425
Titre abrégé: J Cardiovasc Dev Dis
Pays: Switzerland
ID NLM: 101651414

Informations de publication

Date de publication:
27 Feb 2022
Historique:
received: 04 02 2022
revised: 21 02 2022
accepted: 25 02 2022
entrez: 24 3 2022
pubmed: 25 3 2022
medline: 25 3 2022
Statut: epublish

Résumé

Cardiovascular diseases (CVDs) are the major cause of death worldwide. Although the importance of conventional CVD risk factors, including older age, male gender, hypertension, obesity, dyslipidemia and hyperglycemia, is well-studied, psychosocial stress, which is considered an independent CVD risk factor, requires further investigation. Thus, we aimed to investigate the association between long-term secretion of stress-related steroid hormones, including cortisol, cortisone and dehydroepiandrosterone, and the 10-year fatal and non-fatal CVD risk estimated by the SCORE2 risk prediction algorithm, as well as traditional CVD risk factors in a group of apparently healthy women. A total of 145 women (aged 50-64 years) participating in the national CVD prevention program were enrolled in the study. Sociodemographic, lifestyle, health-related characteristics, stress, anxiety and sleep quality indicators were evaluated using specific questionnaires. Anthropometric and arterial blood pressure measures were assessed by trained personnel, lipid and glucose metabolism biomarkers were measured using routine methods, and hair steroid hormone levels were determined by ultra-high-performance liquid chromatography-tandem mass spectrometry. The results showed that higher levels of hair cortisol and cortisone are associated with increased SCORE2 values. Moreover, significant associations between hair glucocorticoids and individual cardiovascular risk factors, including obesity, hypertension, dyslipidemia and hyperglycemia, were found. These findings indicate that stress-related hair steroid hormones might be valuable biomarkers for CVD prediction and prevention.

Identifiants

pubmed: 35323618
pii: jcdd9030070
doi: 10.3390/jcdd9030070
pmc: PMC8955541
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Eur Heart J. 2021 Sep 7;42(34):3227-3337
pubmed: 34458905
Psychoneuroendocrinology. 2017 Jun;80:1-6
pubmed: 28288364
Stress. 2008 Nov;11(6):483-8
pubmed: 18609301
Stress. 2021 Nov;24(6):1008-1015
pubmed: 34633899
J Psychiatr Res. 2019 Oct;117:62-67
pubmed: 31302350
Curr Treat Options Cardiovasc Med. 2019 Apr 26;21(5):23
pubmed: 31028483
J Clin Endocrinol Metab. 2013 May;98(5):2078-83
pubmed: 23596141
Psychoneuroendocrinology. 2019 Jan;99:183-190
pubmed: 30248494
Front Psychiatry. 2021 Jul 06;12:688367
pubmed: 34295276
Lancet. 2004 Sep 11-17;364(9438):953-62
pubmed: 15364186
Nat Rev Cardiol. 2012 Apr 03;9(6):360-70
pubmed: 22473079
Curr Diab Rep. 2019 Jun 20;19(7):44
pubmed: 31222515
Steroids. 2020 Nov;163:108710
pubmed: 32745490
Eur J Pediatr. 2013 Jun;172(6):843-6
pubmed: 23371393
Age Ageing. 2010 Jul;39(4):451-8
pubmed: 20484057
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Sci Rep. 2020 Dec 31;10(1):22456
pubmed: 33384452
J Psychiatr Res. 2017 Jan;84:184-190
pubmed: 27744230
Life (Basel). 2021 Jan 22;11(2):
pubmed: 33499247
Obes Rev. 2022 Mar;23(3):e13376
pubmed: 34811866
Med Sci Monit. 2019 May 14;25:3573-3582
pubmed: 31086129
Hormones (Athens). 2020 Sep;19(3):385-393
pubmed: 32304041
Psychoneuroendocrinology. 2016 Oct;72:212-8
pubmed: 27500952
Psychoneuroendocrinology. 2017 Mar;77:182-185
pubmed: 28073090
Stress. 2019 Mar;22(2):210-220
pubmed: 30663480
Psychoneuroendocrinology. 2019 Mar;101:240-245
pubmed: 30472465
Neuroimmunomodulation. 2015;22(1-2):6-19
pubmed: 25227402
Psychoneuroendocrinology. 2015 Jan;51:365-70
pubmed: 25462908
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Int J Environ Res Public Health. 2021 Nov 22;18(22):
pubmed: 34831996
J Clin Endocrinol Metab. 2013 Jun;98(6):2573-80
pubmed: 23585660
Psychoneuroendocrinology. 2015 Oct;60:182-94
pubmed: 26176863
Biochem Pharmacol. 2013 Mar 15;85(6):718-26
pubmed: 23270992
Can J Cardiol. 2019 May;35(5):653-660
pubmed: 31030866
Curr Cardiol Rep. 2019 Aug 30;21(10):116
pubmed: 31471749
Neurosci Biobehav Rev. 2017 Mar;74(Pt B):297-309
pubmed: 27496672
BMJ Open. 2020 Nov 14;10(11):e038786
pubmed: 33191254
Psychoneuroendocrinology. 2009 Feb;34(2):163-171
pubmed: 19095358
Psychosom Med. 2018 May;80(4):393-402
pubmed: 29521884
Horm Res Paediatr. 2019;92(4):229-236
pubmed: 31851969
Clin Biochem. 2019 Jan;63:1-9
pubmed: 30261181
Sci Rep. 2016 May 12;6:25842
pubmed: 27174654
Physiol Rep. 2021 Jan;8(24):e14644
pubmed: 33340273
Pathology. 2019 Feb;51(2):165-176
pubmed: 30598326
Assessment. 2004 Dec;11(4):330-41
pubmed: 15486169
Brain Behav Immun. 2012 Oct;26(7):1019-29
pubmed: 22366690
Stress. 2018 Mar;21(2):188-193
pubmed: 29373934
Psychoneuroendocrinology. 2016 Nov;73:148-156
pubmed: 27498290
Int J Cardiol Hypertens. 2019 May 30;2:100012
pubmed: 33447745
Atherosclerosis. 2012 Sep;224(1):228-34
pubmed: 22862963
J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3400-e3413
pubmed: 34050761
Psychoneuroendocrinology. 2020 Mar;113:104543
pubmed: 31901730
Stress Health. 2013 Oct;29(4):337-44
pubmed: 23225553
Stress. 2021 Jul;24(4):404-412
pubmed: 33504263
Psychoneuroendocrinology. 2012 May;37(5):589-601
pubmed: 21974976
Psychoneuroendocrinology. 2021 Jan;123:104903
pubmed: 33137562
PLoS One. 2017 Jan 17;12(1):e0169827
pubmed: 28095431
Heart Lung Circ. 2021 Jan;30(1):9-17
pubmed: 32843293
J Affect Disord. 2009 Apr;114(1-3):74-84
pubmed: 18814916
Front Glob Womens Health. 2021 Feb 16;2:606833
pubmed: 34816180
Stress. 2011 Jan;14(1):73-81
pubmed: 20812871
Psychoneuroendocrinology. 2020 Jan;111:104478
pubmed: 31704637
Psychoneuroendocrinology. 2010 Oct;35(9):1404-9
pubmed: 20471757
Psychoneuroendocrinology. 2017 Mar;77:261-274
pubmed: 28135674

Auteurs

Eglė Mazgelytė (E)

Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, M. K. Čiurlionio st. 21, LT-03101 Vilnius, Lithuania.

Neringa Burokienė (N)

Clinics of Internal Diseases, Family Medicine and Oncology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio st. 21, LT-03101 Vilnius, Lithuania.

Agata Vysocka (A)

Clinics of Internal Diseases, Family Medicine and Oncology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio st. 21, LT-03101 Vilnius, Lithuania.

Martynas Narkevičius (M)

Clinics of Internal Diseases, Family Medicine and Oncology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Čiurlionio st. 21, LT-03101 Vilnius, Lithuania.

Tomas Petrėnas (T)

Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, M. K. Čiurlionio st. 21, LT-03101 Vilnius, Lithuania.

Andrius Kaminskas (A)

Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, M. K. Čiurlionio st. 21, LT-03101 Vilnius, Lithuania.

Jurgita Songailienė (J)

Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, M. K. Čiurlionio st. 21, LT-03101 Vilnius, Lithuania.

Algirdas Utkus (A)

Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, M. K. Čiurlionio st. 21, LT-03101 Vilnius, Lithuania.

Dovilė Karčiauskaitė (D)

Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, M. K. Čiurlionio st. 21, LT-03101 Vilnius, Lithuania.

Classifications MeSH